← Leaderboards
W Mark Saltzman
Cornell University Ithaca
$28,702,195
Attributed
$43,880,664
Total exposure
30
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,880,664 · 30
By mechanism
R01$28,963,027 · 13
U01$3,827,594 · 2
UG3$2,442,130 · 1
UH3$2,399,844 · 1
T90$1,964,449 · 1
R56$1,497,366 · 4
Top collaborators
- Jordan S Pober26 shared
- Peter M Glazer22 shared
- George Tellides7 shared
- Akiko Iwasaki5 shared
- Marie E Egan4 shared
- Patrick G Gallagher4 shared
- Priti Kumar4 shared
- Danith H Ly4 shared
Most similar at Cornell University Ithaca
Same institution · by research overlap
- Xingen Lei$2,772,298
- Joel D. Baines$8,813,025
- Thomas Arthur Steitz$12,541,152
- Curt R Dunnam$2,114,526
- Daniel Roberto Ripoll$185,865
Others in their field
Top investigators on “Polymers”
- Marc A Hillmyer · University Of Minnesota-Twin Cities$45,350,238
- Michael F Rubner · Massachusetts Institute Of Technology$44,168,921
- Nicholas Hud · Emory University$41,051,104
- Timothy P Lodge · Gordon Research Conferences$40,942,324
- Eric Baer · Case Western Reserve University$37,476,250
- Robert S Langer · Massachusetts Institute Of Technology$29,222,504
Research focus
PolymersCellsNanoparticleDesignBaseGenesDrug Delivery SystemsIn VivoProteinsMediatingBiomedical EngineeringSiteTechnologyTissuesModificationTransplantationEncapsulatedSurfaceToxic EffectResponseGrantStructurePreventFormulation
Grant awards (122)
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$678,206
R01 · FY2025 · HL
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium$642,639
R01 · FY2025 · AI
Engineering of Polymeric Particles for Fetal Therapy$419,757
R01 · FY2025 · EB · contact PI
Optimizing Therapeutic Revascularization by Endothelial Cell_Transplantation$36,814
R01 · FY2025 · HL
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$678,206
R01 · FY2024 · HL
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium$642,639
R01 · FY2024 · AI
Engineering of Polymeric Particles for Fetal Therapy$412,675
R01 · FY2024 · EB · contact PI
Engineering of Polymeric Particles for Fetal Therapy$431,757
R01 · FY2023 · EB · contact PI
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium$418,250
R56 · FY2023 · AI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$1,144,805
UH3 · FY2022 · HL · contact PI
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$620,196
R01 · FY2022 · HL
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies Supplement$498,197
UH3 · FY2022 · HL · contact PI
PNA Nanoparticles for Gene Editing In Vivo$404,236
U01 · FY2022 · AI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$756,842
UH3 · FY2021 · HL · contact PI
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$620,196
R01 · FY2021 · HL
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium$489,354
U01 · FY2021 · AI
PNA Nanoparticles for Gene Editing In Vivo$404,237
U01 · FY2021 · AI
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium$29,419
U01 · FY2021 · AI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$806,004
UG3 · FY2020 · HL · contact PI
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$598,421
R01 · FY2020 · HL
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium$418,750
U01 · FY2020 · AI
PNA Nanoparticles for Gene Editing In Vivo$404,237
U01 · FY2020 · AI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$384,846
R01 · FY2020 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$818,063
UG3 · FY2019 · HL · contact PI
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis$598,421
R01 · FY2019 · HL
PNA Nanoparticles for Gene Editing In Vivo$421,111
U01 · FY2019 · AI
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium$418,750
U01 · FY2019 · AI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$401,802
R01 · FY2019 · HL · contact PI
Cellular and molecular transport in mucus$396,106
R01 · FY2019 · EB · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$373,300
R01 · FY2019 · CA · contact PI
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung$818,063
UG3 · FY2018 · HL · contact PI
Targeted correction of the human CFTR gene$554,851
R01 · FY2018 · HL
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium$418,750
U01 · FY2018 · AI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$401,802
R01 · FY2018 · HL · contact PI
Cellular and molecular transport in mucus$396,106
R01 · FY2018 · EB · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$384,846
R01 · FY2018 · CA · contact PI
Drug delivery system for enhancing radiation therapy in pediatric glioma$209,375
R21 · FY2018 · HD · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$607,873
R01 · FY2017 · AI
Targeted correction of the human CFTR gene$554,851
R01 · FY2017 · HL
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium$418,750
U01 · FY2017 · AI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$401,802
R01 · FY2017 · HL · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$384,846
R01 · FY2017 · CA · contact PI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$372,359
R01 · FY2017 · HL · contact PI
Cellular and molecular transport in mucus$370,822
R01 · FY2017 · EB · contact PI
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research$310,783
T32 · FY2017 · DK · contact PI
Drug delivery system for enhancing radiation therapy in pediatric glioma$251,250
R21 · FY2017 · HD · contact PI
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research$3,352
T32 · FY2017 · DK · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$607,873
R01 · FY2016 · AI
Targeted correction of the human CFTR gene$554,851
R01 · FY2016 · HL
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$401,802
R01 · FY2016 · HL · contact PI
Vaginally-delivered Nanoparticles for Prevention and Treatment of HSV-2 Infections$385,981
R56 · FY2016 · AI · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$375,710
R01 · FY2016 · CA · contact PI
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research$329,238
T32 · FY2016 · DK · contact PI
Targeting Nanoparticles for Drug Delivery to Renal Graft Endothelium during Ex Vivo Normothermic Perfusion$251,250
R21 · FY2016 · AI · contact PI
Cellular and molecular transport in mucus$1
R01 · FY2016 · EB · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$607,873
R01 · FY2015 · AI
Targeted correction of the human CFTR gene$554,851
R01 · FY2015 · HL
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$399,840
R01 · FY2015 · HL · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$343,413
R01 · FY2015 · CA · contact PI
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research$300,108
T32 · FY2015 · DK · contact PI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$397,811
R01 · FY2014 · HL · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$333,111
R01 · FY2014 · CA · contact PI
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research$281,925
T32 · FY2014 · DK · contact PI
In vivo genomic editing of hematopoietic cells for HIV resistance$250,000
R01 · FY2014 · AI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$386,443
R01 · FY2013 · HL · contact PI
Bioengineered siRNA/Nanoparticles to Prevent Human Transplant Rejection$291,000
R56 · FY2013 · AI · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$290,527
R01 · FY2013 · CA · contact PI
Yale Interdisciplinary Bioengineering Training Grant for Diabetes Research$269,834
T32 · FY2013 · DK · contact PI
Molecular and Cellular Transport in Mucus$533,860
R01 · FY2012 · EB · contact PI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$404,758
R01 · FY2012 · HL · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$309,071
R01 · FY2012 · CA · contact PI
Spatiotemporal Delivery of miRNA Anatgomir for Promoting Vascular Self-Assembly$249,063
R21 · FY2012 · HL · contact PI
Molecular and Cellular Transport in Mucus$533,217
R01 · FY2011 · EB · contact PI
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation$403,586
R01 · FY2011 · HL · contact PI
CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas$309,071
R01 · FY2011 · CA · contact PI
Controlled Spatiotemporal Delivery of miRNA Anatgomir for Promoting Vascular Self$206,927
R21 · FY2011 · HL · contact PI
MOLECULAR AND CELLULAR TRANSPORT IN MUCUS$15,795
P51 · FY2011 · RR · contact PI
Molecular and Cellular Transport in Mucus$536,588
R01 · FY2010 · EB · contact PI
Optimizing Revascularization by EC Transplantation$390,654
R01 · FY2010 · HL · contact PI
MOLECULAR AND CELLULAR TRANSPORT IN MUCUS$47,970
P51 · FY2010 · RR · contact PI
Molecular and Cellular Transport in Mucus$540,396
R01 · FY2009 · EB · contact PI
Optimizing Revascularization by EC Transplantation$391,131
R01 · FY2009 · HL · contact PI
Interdisciplinary Pre-doctoral Training Program in Neuroengineering(RMI)$435,743
T90 · FY2008 · DK · contact PI
Molecular and Cellular Transport in Mucus$402,135
R56 · FY2008 · EB · contact PI
Optimizing Revascularization by EC Transplantation$391,493
R01 · FY2008 · HL · contact PI
Interdisciplinary Pre-doctoral Training Program in Neuroengineering(RMI)$10,924
R90 · FY2008 · DK · contact PI
Interdisciplinary Pre-doctoral Training Program in Neuroengineering(RMI)$401,959
T90 · FY2007 · DK · contact PI
Optimizing Revascularization by EC Transplantation$390,886
R01 · FY2007 · HL · contact PI
Microfluidic/controlled systems on brain microprobes$250,816
R01 · FY2007 · NS · contact PI
Interdisciplinary Pre-doctoral Training Program in Neuroengineering(RMI)$9,455
R90 · FY2007 · DK · contact PI
Pre-doctoral Training Program in Neuroengineering$437,518
T90 · FY2006 · DK · contact PI
Optimizing Revascularization by EC Transplantation$402,989
R01 · FY2006 · HL · contact PI
Molecular and cellular transport in mucus$329,232
R01 · FY2006 · EB · contact PI
Micro-and Nano-engineering of Biomineralized Materials$272,599
R01 · FY2006 · DE · contact PI
Microfluidic/controlled systems on brain microprobes$256,577
R01 · FY2006 · NS · contact PI
Pre-doctoral Training Program in Neuroengineering$43,752
T90 · FY2006 · DK · contact PI
Interdisciplinary Pre-doctoral Training Program in Neur*$10,924
R90 · FY2006 · DK · contact PI
Pre-doctoral Training Program in Neuroengineering(RMI)$426,718
T90 · FY2005 · DK
Molecular and cellular transport in mucus$340,442
R01 · FY2005 · EB
Micro-and Nano-engineering of Biomineralized Materials$277,064
R01 · FY2005 · DE
Microfluidic/controlled systems on brain microprobes$261,077
R01 · FY2005 · NS
Interdisciplinary Pre-doctoral Train Program Neur*(RMI)$17,157
R90 · FY2005 · DK
Molecular and cellular transport in mucus$343,897
R01 · FY2004 · EB
Micro-and Nano-engineering of Biomineralized Materials$276,034
R01 · FY2004 · DE
Microfluidic/controlled systems on brain microprobes$259,459
R01 · FY2004 · NS
Pre-doctoral Training Program in Neuroengineering (RMI)$218,759
T90 · FY2004 · DK
Pre-doctoral Training Program in Neuroengineering (RMI)$10,924
R90 · FY2004 · DK
Molecular and cellular transport in mucus$347,066
R01 · FY2003 · EB
Micro-and Nano-engineering of Biomineralized Materials$275,026
R01 · FY2003 · DE
Microfluidic/controlled systems on brain microprobes$273,770
R01 · FY2003 · NS
Molecular and cellular transport in mucus$366,388
R01 · FY2002 · EB
Micro-and Nano-engineering of Biomineralized Materials$302,702
R01 · FY2002 · DE
CONSTRUCTING NEUROTROPHIN FIELDS IN THE BRAIN$185,897
R01 · FY2002 · NS
MODELING OF DRUG TRANSPORT FOR BRAIN TUMOR THERAPY$0
U19 · FY2002 · CA
MOLECULAR AND CELLULAR TRANSPORT IN MUCUS$294,716
R01 · FY2001 · GM
CONSTRUCTING NEUROTROPHIN FIELDS IN THE BRAIN$180,487
R01 · FY2001 · NS
MODELING OF DRUG TRANSPORT FOR BRAIN TUMOR THERAPY$0
U19 · FY2001 · CA
MOLECULAR AND CELLULAR TRANSPORT IN MUCUS$286,603
R01 · FY2000 · GM
CONSTRUCTING NEUROTROPHIN FIELDS IN THE BRAIN$175,230
R01 · FY2000 · NS
MODELING OF DRUG TRANSPORT FOR BRAIN TUMOR THERAPY$0
U19 · FY2000 · CA
MODELING OF DRUG TRANSPORT FOR BRAIN TUMOR THERAPY$0
U19 · FY2000 · CA
MODELING OF DRUG TRANSPORT FOR BRAIN TUMOR THERAPY$0
U19 · FY2000 · CA